Multicenter Randomized Controlled Clinical Trial of Mabuterol Hydrochloride Tablets Versus Procaterol Hydrochloride in the Treatment of Bronchial Asthma

CHANG Chun,WANG Xiao-hong,YAO Wan-zhen,ZHANG Hu-sheng,WANG Qiu-yue,CHEN Ping,LIU Li-hua

DOI: https://doi.org/10.3969/j.issn.1001-6821.2011.01.002

2011-01-01

Abstract:Objective To evaluate the efficacy and safety of mabuterol compared with procaterol in the treatment of mild and moderate bronchial asthma.Methods This study was designed as a prospective and parallel randomized controlled clinical trial.There were 120 and 120 patients in trial group and controlled group,respectively.All the randomized were administered for 7 days and evaluated the efficacy and safety.Results Comparison with pre-treatment,the symptom score and sign score,the forced expiratory volumn in 1 second(FEVI) and the peak expiratory flow(PEF) were obviously improved in both trial group and control group(P0.05).The clinical and lung function(FEV1) efficacy of 7 days duration were 86.67% and 20.51% respectively which were compared with those of procaterol(82.73% and 18.48%,P0.05).The adverse drug reaction rate of mabuterol was 18.80% and that of the controlled was 11.76%(P0.05).Conclusion Mabuterol was effective and safe in the treatment of mild and moderate bronchial asthma.